Clinical Trials Directory

Trials / Unknown

UnknownNCT01482585

Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy

Prospective Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

to determine the values of imaging and genetic biomarkers for prediction of tumor aggressiveness and prognosis in patient with early stage lung adenocarcinoma to Identify unique copy number alteration in patient with early stage lung adenocarcinoma to evaluate the long-term change of ground-glass nodule combined with lung adenocarcinoma to suggest a guideline for planning an appropriate follow-up examination and management

Conditions

Interventions

TypeNameDescription
OTHERCT, PET, copy number alterationDuel-energy CT, PET, copy number alteration

Timeline

Start date
2011-10-01
Primary completion
2016-07-01
Completion
2016-12-01
First posted
2011-11-30
Last updated
2011-11-30

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01482585. Inclusion in this directory is not an endorsement.